vs
Side-by-side financial comparison of Axsome Therapeutics, Inc. (AXSM) and Gogo Inc. (GOGO). Click either name above to swap in a different company.
Gogo Inc. is the larger business by last-quarter revenue ($230.6M vs $196.0M, roughly 1.2× Axsome Therapeutics, Inc.). Gogo Inc. runs the higher net margin — -4.3% vs -14.6%, a 10.2% gap on every dollar of revenue. On growth, Gogo Inc. posted the faster year-over-year revenue change (67.3% vs 65.0%). Axsome Therapeutics, Inc. produced more free cash flow last quarter ($-18.7M vs $-25.4M). Over the past eight quarters, Axsome Therapeutics, Inc.'s revenue compounded faster (61.7% CAGR vs 48.7%).
Jazz Pharmaceuticals plc is a global biopharmaceutical company with a focus on oncology and neuroscience. It was founded in 2003 in California, United States and is now headquartered in Dublin, Ireland.
Gogo Inc. is an American provider of in-flight broadband Internet service and other connectivity services for business aircraft, headquartered in Broomfield, Colorado. Through its Gogo LLC subsidiary, Gogo previously provided in-flight WiFi to 17 airlines until the Commercial Air business was sold to Intelsat for $400 million in December 2020. According to Gogo, over 2,500 commercial aircraft and 6,600 business aircraft have been equipped with its onboard Wi-Fi services. The company is the de...
AXSM vs GOGO — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $196.0M | $230.6M |
| Net Profit | $-28.6M | $-10.0M |
| Gross Margin | — | — |
| Operating Margin | -13.8% | 6.2% |
| Net Margin | -14.6% | -4.3% |
| Revenue YoY | 65.0% | 67.3% |
| Net Profit YoY | 61.9% | 64.6% |
| EPS (diluted) | $-0.55 | $-0.08 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $196.0M | $230.6M | ||
| Q3 25 | $171.0M | $223.6M | ||
| Q2 25 | $150.0M | $226.0M | ||
| Q1 25 | $121.5M | $230.3M | ||
| Q4 24 | $118.8M | $137.8M | ||
| Q3 24 | $104.8M | $100.5M | ||
| Q2 24 | $87.2M | $102.1M | ||
| Q1 24 | $75.0M | $104.3M |
| Q4 25 | $-28.6M | $-10.0M | ||
| Q3 25 | $-47.2M | $-1.9M | ||
| Q2 25 | $-48.0M | $12.8M | ||
| Q1 25 | $-59.4M | $12.0M | ||
| Q4 24 | $-74.9M | $-28.2M | ||
| Q3 24 | $-64.6M | $10.6M | ||
| Q2 24 | $-79.3M | $839.0K | ||
| Q1 24 | $-68.4M | $30.5M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 87.8% | ||
| Q1 25 | — | 87.3% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | -13.8% | 6.2% | ||
| Q3 25 | -27.0% | 12.9% | ||
| Q2 25 | -24.5% | 15.9% | ||
| Q1 25 | -46.9% | 15.3% | ||
| Q4 24 | -61.1% | -17.5% | ||
| Q3 24 | -59.8% | 19.0% | ||
| Q2 24 | -89.5% | 21.2% | ||
| Q1 24 | -89.7% | 33.2% |
| Q4 25 | -14.6% | -4.3% | ||
| Q3 25 | -27.6% | -0.9% | ||
| Q2 25 | -32.0% | 5.7% | ||
| Q1 25 | -48.9% | 5.2% | ||
| Q4 24 | -63.1% | -20.5% | ||
| Q3 24 | -61.7% | 10.6% | ||
| Q2 24 | -91.0% | 0.8% | ||
| Q1 24 | -91.1% | 29.2% |
| Q4 25 | $-0.55 | $-0.08 | ||
| Q3 25 | $-0.94 | $-0.01 | ||
| Q2 25 | $-0.97 | $0.09 | ||
| Q1 25 | $-1.22 | $0.09 | ||
| Q4 24 | $-1.54 | $-0.22 | ||
| Q3 24 | $-1.34 | $0.08 | ||
| Q2 24 | $-1.67 | $0.01 | ||
| Q1 24 | $-1.44 | $0.23 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $322.9M | $125.2M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $88.3M | $101.1M |
| Total Assets | $689.8M | $1.3B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $322.9M | $125.2M | ||
| Q3 25 | $325.3M | $133.6M | ||
| Q2 25 | $303.0M | $102.1M | ||
| Q1 25 | $300.9M | $70.3M | ||
| Q4 24 | $315.4M | $41.8M | ||
| Q3 24 | $327.3M | $176.7M | ||
| Q2 24 | $315.7M | $161.6M | ||
| Q1 24 | $331.4M | $152.8M |
| Q4 25 | $88.3M | $101.1M | ||
| Q3 25 | $73.7M | $107.0M | ||
| Q2 25 | $73.1M | $102.8M | ||
| Q1 25 | $53.2M | $82.9M | ||
| Q4 24 | $57.0M | $69.3M | ||
| Q3 24 | $92.9M | $52.7M | ||
| Q2 24 | $102.9M | $52.0M | ||
| Q1 24 | $144.0M | $62.4M |
| Q4 25 | $689.8M | $1.3B | ||
| Q3 25 | $669.3M | $1.3B | ||
| Q2 25 | $639.8M | $1.3B | ||
| Q1 25 | $596.7M | $1.2B | ||
| Q4 24 | $568.5M | $1.2B | ||
| Q3 24 | $561.5M | $810.7M | ||
| Q2 24 | $548.2M | $802.7M | ||
| Q1 24 | $545.7M | $809.0M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-18.7M | $8.5M |
| Free Cash FlowOCF − Capex | $-18.7M | $-25.4M |
| FCF MarginFCF / Revenue | -9.6% | -11.0% |
| Capex IntensityCapex / Revenue | 0.0% | 14.7% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-93.9M | $65.1M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-18.7M | $8.5M | ||
| Q3 25 | $1.0M | $46.8M | ||
| Q2 25 | $-32.4M | $36.7M | ||
| Q1 25 | $-43.4M | $32.5M | ||
| Q4 24 | $-26.2M | $-38.3M | ||
| Q3 24 | $-18.6M | $25.1M | ||
| Q2 24 | $-30.1M | $24.9M | ||
| Q1 24 | $-53.5M | $29.7M |
| Q4 25 | $-18.7M | $-25.4M | ||
| Q3 25 | $988.0K | $27.3M | ||
| Q2 25 | $-32.4M | $33.5M | ||
| Q1 25 | $-43.7M | $29.7M | ||
| Q4 24 | $-26.2M | $-42.6M | ||
| Q3 24 | $-18.7M | $20.7M | ||
| Q2 24 | $-30.2M | $21.6M | ||
| Q1 24 | $-53.6M | $28.2M |
| Q4 25 | -9.6% | -11.0% | ||
| Q3 25 | 0.6% | 12.2% | ||
| Q2 25 | -21.6% | 14.8% | ||
| Q1 25 | -36.0% | 12.9% | ||
| Q4 24 | -22.1% | -30.9% | ||
| Q3 24 | -17.9% | 20.6% | ||
| Q2 24 | -34.6% | 21.1% | ||
| Q1 24 | -71.4% | 27.0% |
| Q4 25 | 0.0% | 14.7% | ||
| Q3 25 | 0.0% | 8.7% | ||
| Q2 25 | 0.0% | 1.4% | ||
| Q1 25 | 0.3% | 1.2% | ||
| Q4 24 | 0.0% | 3.1% | ||
| Q3 24 | 0.1% | 4.4% | ||
| Q2 24 | 0.1% | 3.3% | ||
| Q1 24 | 0.1% | 1.4% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 2.87× | ||
| Q1 25 | — | 2.70× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 2.36× | ||
| Q2 24 | — | 29.74× | ||
| Q1 24 | — | 0.97× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
AXSM
Segment breakdown not available.
GOGO
| Services | $191.9M | 83% |
| Products | $38.7M | 17% |
| Fcc Reimbursement Program | $2.0M | 1% |
